A detailed history of Marks Group Wealth Management, Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Marks Group Wealth Management, Inc holds 18,878 shares of NVO stock, worth $1.98 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
18,878
Previous 18,891 0.07%
Holding current value
$1.98 Million
Previous $2.7 Million 16.65%
% of portfolio
0.22%
Previous 0.3%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$119.07 - $145.42 $1,547 - $1,890
-13 Reduced 0.07%
18,878 $2.25 Million
Q2 2024

Aug 14, 2024

SELL
$122.71 - $146.91 $123,691 - $148,085
-1,008 Reduced 5.07%
18,891 $2.7 Million
Q1 2024

Apr 29, 2024

SELL
$102.11 - $135.92 $61,572 - $81,959
-603 Reduced 2.94%
19,899 $2.56 Million
Q4 2023

Feb 01, 2024

BUY
$87.78 - $105.45 $9,304 - $11,177
106 Added 0.52%
20,502 $2.12 Million
Q3 2023

Oct 30, 2023

BUY
$90.94 - $199.54 $878,207 - $1.93 Million
9,657 Added 89.92%
20,396 $1.85 Million
Q2 2023

Jul 19, 2023

BUY
$155.98 - $172.65 $309,464 - $342,537
1,984 Added 22.66%
10,739 $1.74 Million
Q1 2023

May 03, 2023

BUY
$132.34 - $159.14 $7,808 - $9,389
59 Added 0.68%
8,755 $1.39 Million
Q4 2022

Feb 06, 2023

BUY
$102.55 - $135.33 $36,097 - $47,636
352 Added 4.22%
8,696 $1.18 Million
Q3 2022

Nov 10, 2022

SELL
$95.28 - $116.93 $19,532 - $23,970
-205 Reduced 2.4%
8,344 $832,000
Q2 2022

Aug 09, 2022

SELL
$103.24 - $121.81 $380,026 - $448,382
-3,681 Reduced 30.1%
8,549 $952,000
Q1 2022

May 10, 2022

BUY
$93.1 - $112.54 $188,155 - $227,443
2,021 Added 19.8%
12,230 $1.36 Million
Q4 2021

Feb 14, 2022

BUY
$95.88 - $117.08 $425,707 - $519,835
4,440 Added 76.96%
10,209 $1.07 Million
Q3 2021

Nov 15, 2021

BUY
$84.42 - $106.62 $286,268 - $361,548
3,391 Added 142.6%
5,769 $552,000
Q2 2021

Aug 10, 2021

BUY
$67.66 - $84.76 $160,895 - $201,559
2,378 New
2,378 $200,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Marks Group Wealth Management, Inc Portfolio

Follow Marks Group Wealth Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marks Group Wealth Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Marks Group Wealth Management, Inc with notifications on news.